A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

ישראלמגייס משתתפיםPHASE3

מצבים רפואיים

Mania · Bipolar Disorder

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Pillar Clinical Research - Bentonville, Bentonville, Arkansas, United States

    Contact: Study coordinator (Fayz Hudefi) · 479-367-2688
  • Pillar Clinical Research- Little Rock, Little Rock, Arkansas, United States

    Contact: Study coordinator (Leslie Smith) · 501-350-3285
  • Clinical Innovations, Inc. dba CITrials, Bellflower, California, United States

    Contact: Study coordinator (Gerald Maguire) · 562-249-6956
  • Inland Psychiatric Medical Group., Chino, California, United States

    Contact: Study coordinator (Nandita Puchakayala) · 909-488-9116
  • Proscience Research Group, Culver City, California, United States

    Contact: Study coordinator (Marina Bussel) · 424-227-8127
  • Omega Clinical Trials - La Habra, La Habra, California, United States

    Contact: Study coordinator (Wakelin McNeel) · 562-690-2200
  • Catalina Research Institute, LLC, Montclair, California, United States

    Contact: Study coordinator (Stephen Volk) · 909-590-8409
  • NRC Research Institute, Orange, California, United States

    Contact: Study coordinator (Tony Ortiz) · 714-289-1100
  • Clinical Innovations, Inc. dba CITrials, Riverside, California, United States

    Contact: Study coordinator (Evagelos Coskinas) · 951-300-4924
  • Velocity Clinical Research, Hallandale Beach, Hallandale, Florida, United States

    Contact: Study coordinator (Beth Safirstein)
  • South Florida Research Phase I-IV, Miami, Florida, United States

    Contact: Study coordinator (Silvia Silva Duluc) · 305-669-6166
  • Health Synergy Clinical Research, West Palm Beach, Florida, United States

    Contact: Study coordinator (Mohammad Nisar) · 786-831-7303
  • CenExel iResearch, LLC, Savannah, Georgia, United States

    Contact: Study coordinator (Yael Elfassy) · 912-744-0800
  • Pillar Clinical Research -Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Roueen Rafeyan) · 312-865-6336
  • Arch Clinical Trials, St Louis, Missouri, United States

    Contact: Study coordinator (Junaid Syed) · 314-771-6387
  • Richmond Behavioral Associates, Staten Island, New York, United States

    Contact: Study coordinator (Peter Weiden) · 917-701-7484
  • Community Clinical Research, Austin, Texas, United States

    Contact: Study coordinator (David Brown) · 512-323-2622
  • Elevate Clinical Research-Houston, Houston, Texas, United States

    Contact: Study coordinator (Matthew Brams)
  • Prime Clinical Research - Mansfield, Mansfield, Texas, United States

    Contact: Study coordinator (Jamie Alexander) · 817-907-7330
  • Pillar Clinical Research - Richardson, Richardson, Texas, United States

    Contact: Study coordinator (Scott Bartley) · 214-396-4844
  • Local Institution - 0011, ABB, Buenos Aires F.D., Argentina

  • Local Institution - 0010, Córdoba, Argentina

  • Local Institution - 0012, Córdoba, Argentina

  • Local Institution - 0008, Córdoba, Argentina

  • Local Institution - 0009, Mendoza, Argentina

  • Local Institution - 0114, Santiago del Estero, Argentina

  • Local Institution - 0184, Kazanlak, Stara Zagora, Bulgaria

  • State Psychiatric Hospital Sv. Ivan Rilski Novi Iskar, Novi Iskar, Bulgaria

    Contact: Study coordinator (Tsveteslava Galabova) · 359892444643
  • "University Multiprofile Hospital for Active Treatment - Dr. Georgi Stranski" EAD, Pleven, Bulgaria

    Contact: Study coordinator (Maya Stoimenova - Popova) · +359888227165
  • Local Institution - 0084, Pleven, Bulgaria

  • Local Institution - 0181, Sliven, Bulgaria

  • Local Institution - 0086, Targovishte, Bulgaria

  • Local Institution - 0185, Beijing, Beijing Municipality, China

  • Local Institution - 0190, Beijing, Beijing Municipality, China

  • Local Institution - 0191, Guangzhou, Guangdong, China

  • Local Institution - 0193, Baoding, Hebei, China

  • Local Institution - 0187, Shijiazhuang, Hebei, China

  • Local Institution - 0196, Nanjing, Jiangsu, China

  • Local Institution - 0186, Xi'an, Shaanxi, China

  • Local Institution - 0192, Chengdu, Sichuan, China

  • Local Institution - 0188, Tianjin, Tianjin Municipality, China

  • Local Institution - 0197, Ningbo, Zhejiang, China

  • Local Institution - 0195, Changsha, China

  • Local Institution - 0088, Hillerød, Capital Region, Denmark

  • Local Institution - 0054, Aalborg, North Denmark, Denmark

  • Local Institution - 0091, Glostrup Municipality, Denmark

  • Local Institution - 0126, Nice, Alpes-Maritimes, France

  • Local Institution - 0085, Clermont-Ferrand, Puy-de-Dôme, France

  • Local Institution - 0087, Marseille, France

  • Local Institution - 0129, Montpellier, France

  • Local Institution - 0089, Paris, France

  • Local Institution - 0121, Mangalore, Karnataka, India

  • Local Institution - 0123, Madurai, Tamil Nadu, India

  • Local Institution - 0118, Kolkata, West Bengal, India

  • Local Institution - 0116, Kolkata, India

  • Local Institution - 0052, Hod HaSharon, Central District, Israel

  • Sheba Medical Center, Ramat Gan, Central District, Israel

    Contact: Study coordinator (Linda Levi-Haramati) · 0585950299
  • Local Institution - 0053, Ashkelon, Southern District, Israel

  • Be'er Sheva Mental Health Center, Beersheba, Southern District, Israel

    Contact: Study coordinator (Yuli Bersudsky)
  • Local Institution - 0200, Bnei Brak, Israel

  • Local Institution - 0083, Jerusalem, Israel

  • Local Institution - 0003, Milan, Lombardy, Italy

  • Local Institution - 0005, Pisa, Tuscany, Italy

  • Local Institution - 0001, Siena, Tuscany, Italy

  • Local Institution - 0004, Ancona, Italy

  • Local Institution - 0002, Genova, Italy

  • Okehazama Hospital, Toyoake, Aichi-ken, Japan

    Contact: Study coordinator (kiyoshi Fujita) · 0562971361
  • Local Institution - 0205, Ichikawa, Chiba, Japan

  • Local Institution - 0172, Iizuka, Fukuoka, Japan

  • Local Institution - 0141, Kitakyushu-shi, Fukuoka, Japan

  • Goryokai Medical Corporation - Goryokai Hospital, Sapporo, Hokkaido, Japan

    Contact: Study coordinator (Kimihiro Nakajima) · +81-11-771-5660
  • Local Institution - 0107, Yokohama, Kanagawa, Japan

  • Rainbow and Sea Hospital, Karatsu, Saga-ken, Japan

    Contact: Study coordinator (Taro Shindo) · 0955770711
  • Local Institution - 0180, Bunkyo-ku, Tokyo, Japan

  • Nippon Medical School Hospital, Bunkyo-ku, Tokyo, Japan

    Contact: Study coordinator (Amane Tateno) · +81-3-3822-2131
  • Local Institution - 0201, Kodaira, Tokyo, Japan

  • Narimasu Kosei Hospital, tabashi City, Tokyo, Japan

    Contact: Study coordinator (Yuya Tenjin) · 0339391191
  • Kuramitsu Hospital, Fukuoka, Japan

    Contact: Study coordinator (Noriko Tamaru) · +81-92-811-1821
  • Kochi Health Sciences Center, Kochi, Japan

    Contact: Study coordinator (Ken Sawada) · +81-88-837-3000
  • Instytut Psychiatrii i Neurologii, Warsaw, Masovian Voivodeship, Poland

    Contact: Study coordinator (Adam Wichniak) · +48600-107-410
  • Local Institution - 0103, Rybnik, Silesian Voivodeship, Poland

  • Clinica Inventiva, Tuszyn, Poland

    Contact: Study coordinator (Jaroslaw Strzelec) · 602305132
  • Local Institution - 0093, Bucharest, Bucharest, Romania

  • Prof. Dr. Alexandru Obregia Psychiatry Hospital, Bucharest, Bucharest, Romania

    Contact: Study coordinator (Valentin Matei) · +40721243869
  • Prof. Dr. Alexandru Obregia Psychiatry Hospital, Bucharest, Bucharest, Romania

    Contact: Study coordinator (ADELA CIOBANU) · 0040723671301
  • Prof. Dr. Alexandru Obregia Psychiatry Hospital, Bucharest, Bucharest, Romania

    Contact: Study coordinator (Laura Cristina Dolis) · 0040757243543
  • Prof. Dr. Alexandru Obregia Psychiatry Hospital, Bucharest, Bucharest, Romania

    Contact: Study coordinator (Mihnea Manea) · 0040745974029
  • Local Institution - 0102, Bucharest, Romania

  • Local Institution - 0099, Bucharest, Romania

  • Local Institution - 0203, Bucharest, Romania

  • Local Institution - 0097, Iași, Romania

  • Spitalul de Psihiatrie și Neurologie Brașov, Sanpetru /Brasov, Romania

    Contact: Study coordinator (Petru Ifteni) · 0040724993329
  • Local Institution - 0101, Sibiu, Romania

  • Local Institution - 0167, Smila, Cherkasy Oblast, Ukraine

  • Local Institution - 0165, Dnipro, Dnipropetrovsk Oblast, Ukraine

  • Local Institution - 0178, Skarzhyntsi, Khmelnytskyi Oblast, Ukraine

  • Local Institution - 0163, Nove, Kirovohrad Oblast, Ukraine

  • Local Institution - 0169, Hlevakha, Kyivska Oblast, Ukraine

  • Local Institution - 0162, Kyiv, Kyivska Oblast, Ukraine

  • Local Institution - 0164, Lviv, Lviv Oblast, Ukraine

  • Local Institution - 0206, Ternopil, Ternopil Oblast, Ukraine

  • Local Institution - 0168, Vinnytsia, Vinnytsia Oblast, Ukraine

  • Local Institution - 0170, Odesa, Ukraine

  • Local Institution - 0171, Odesa, Ukraine

  • Local Institution - 0177, Poltava, Ukraine

מובילי המחקר
  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb